Clinical Research Facility

Jackson, Michigan

We've found

2 trials

at this facility

Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Status: Enrolling, Phase II
Updated: 2/26/2016

from

Jackson, MI

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Jackson, MI

Use our guide to learn which trials are right for you!